Obesity
Q&A: How women with PCOS can boost fertility
Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Judy Simon, MS, RDN, CD, CHES, FAND, about nutrition and other lifestyle considerations for women with polycystic ovary syndrome seeking to conceive.
Q&A: ‘Dawn of a new era for OSA care’ moving into 2025
Entering 2025, adults with moderate to severe obstructive sleep apnea and obesity have a new FDA-approved treatment option that takes the form of a GIP/GLP-1 dual agonist, according to a press release from Eli Lilly and Company.
Sculptra, hyaluronic filler regimen corrects facial sagging from GLP-1-induced weight loss
New data suggest Restylane Lyft or Contour in combination with Sculptra corrects contour deficiencies in patients experiencing facial volume loss following medication-driven weight loss, according to a Galderma press release.
Aerobic exercise linked to reduced belly, body fat among those with obesity
Aerobic exercise has been linked to reductions in several measures of body fat, including body weight and waist circumference, a systematic review and meta-analysis in JAMA Network Open found.
Gestational diabetes, asthma link highlights need for early screening in pregnant women
Gestational diabetes led to an increased risk for asthma exacerbations during pregnancy among a cohort of women with pre-existing asthma, according to results of a retrospective cohort study.
Race, sex disparities persist in weight-loss surgery
Men were less likely than women to have weight-loss surgery, and that gap has widened over time, while Black patients were less likely than those of other races to have a procedure, and that gap has narrowed slightly, new data show.
Top in endocrinology: Novel GLP-1 lowers weight; osteoporosis detection with CT plus AI
Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according to a presentation at World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.
Lancet report offers a ‘new reframing’ for defining, diagnosing obesity
A new international commission report has proposed new criteria for diagnosing obesity that could dramatically change the way it is categorized and managed in the future.
Prucalopride still effective in CIC despite older age, unhealthy BMI or renal impairment
Prucalopride was safe and effective in increasing the frequency of complete spontaneous bowel movements in patients with chronic idiopathic constipation, regardless of age, BMI or renal function, according to data.
GLP-1s reduce weight, with investigational therapies potentially more effective
A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without diabetes, a systematic review published in Annals of Internal Medicine showed.